Følg
Paul Peter Tak
Paul Peter Tak
Candel Therapeutics, GlaxoSmithKline, Kintai Therapeutics, Academic Medical Center, Amsterdam
Verifisert e-postadresse på candeltx.com - Startside
Tittel
Sitert av
Sitert av
År
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ...
Arthritis & rheumatism 62 (9), 2569-2581, 2010
158922010
NF-κB: a key role in inflammatory diseases
PP Tak, GS Firestein
The Journal of clinical investigation 107 (1), 7-11, 2001
50642001
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ...
Nature 506 (7488), 376-381, 2014
26362014
Tumor necrosis factor antagonist mechanisms of action: a comprehensive review
D Tracey, L Klareskog, EH Sasso, JG Salfeld, PP Tak
Pharmacology & therapeutics 117 (2), 244-279, 2008
22062008
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
EA Stahl, S Raychaudhuri, EF Remmers, G Xie, S Eyre, BP Thomson, Y Li, ...
Nature genetics 42 (6), 508-514, 2010
16272010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
W Hueber, DD Patel, T Dryja, AM Wright, I Koroleva, G Bruin, C Antoni, ...
Science translational medicine 2 (52), 52ra72-52ra72, 2010
11012010
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
FA Koopman, SS Chavan, S Miljko, S Grazio, S Sokolovic, PR Schuurman, ...
Proceedings of the National Academy of Sciences 113 (29), 8284-8289, 2016
10112016
2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of …
A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ...
Annals of the Rheumatic Diseases 75 (3), 481-489, 2016
9572016
MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
Y Tang, X Luo, H Cui, X Ni, M Yuan, Y Guo, X Huang, H Zhou, N de Vries, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
9342009
Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity
PP Tak, TJM Smeets, MR Daha, PM Kluin, KAE Meijers, R Brand, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1997
7481997
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
JC Robson, PC Grayson, C Ponte, R Suppiah, A Craven, A Judge, ...
Arthritis & Rheumatology 74 (3), 393-399, 2022
745*2022
Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
GM Bartelds, CA Wijbrandts, MT Nurmohamed, S Stapel, WF Lems, ...
Annals of the rheumatic diseases 66 (7), 921-926, 2007
7372007
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
J Braun, T Pham, J Sieper, J Davis, SJ Van der Linden, M Dougados, ...
Annals of the rheumatic diseases 62 (9), 817-824, 2003
6322003
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies
L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ...
Annals of the rheumatic diseases 71 (1), 4-12, 2012
6282012
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
GJ Wolbink, M Vis, W Lems, AE Voskuyl, E De Groot, MT Nurmohamed, ...
Arthritis & Rheumatism 54 (3), 711-715, 2006
6272006
Common variants at CD40 and other loci confer risk of rheumatoid arthritis
S Raychaudhuri, EF Remmers, AT Lee, R Hackett, C Guiducci, NP Burtt, ...
Nature genetics 40 (10), 1216-1223, 2008
6222008
The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis
PP Tak, B Bresnihan
Arthritis & Rheumatism 43 (12), 2619-2633, 2000
5562000
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
JJ Haringman, DM Gerlag, AH Zwinderman, TJM Smeets, MC Kraan, ...
Annals of the rheumatic diseases 64 (6), 834-838, 2005
5522005
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
MH Buch, JS Smolen, N Betteridge, FC Breedveld, G Burmester, T Dörner, ...
Annals of the rheumatic diseases 70 (6), 909-920, 2011
5492011
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ...
Annals of the rheumatic diseases 71 (5), 638-641, 2012
5442012
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20